ID   ITAM_HUMAN              Reviewed;        1152 AA.
AC   P11215; Q4VAK0; Q4VAK2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-FEB-2012, entry version 139.
DE   RecName: Full=Integrin alpha-M;
DE   AltName: Full=CD11 antigen-like family member B;
DE   AltName: Full=CR-3 alpha chain;
DE   AltName: Full=Cell surface glycoprotein MAC-1 subunit alpha;
DE   AltName: Full=Leukocyte adhesion receptor MO1;
DE   AltName: Full=Neutrophil adherence receptor;
DE   AltName: CD_antigen=CD11b;
DE   Flags: Precursor;
GN   Name=ITGAM; Synonyms=CD11B, CR3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=88315033; PubMed=2457584;
RA   Corbi A.L., Kishimoto T.K., Miller L.J., Springer T.A.;
RT   "The human leukocyte adhesion glycoprotein Mac-1 (complement receptor
RT   type 3, CD11b) alpha subunit. Cloning, primary structure, and relation
RT   to the integrins, von Willebrand factor and factor B.";
RL   J. Biol. Chem. 263:12403-12411(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=88190151; PubMed=2833753; DOI=10.1073/pnas.85.8.2776;
RA   Arnaout M.A., Remold-O'Donnell E., Pierce M.W., Harris P., Tenen D.G.;
RT   "Molecular cloning of the alpha subunit of human and guinea pig
RT   leukocyte adhesion glycoprotein Mo1: chromosomal localization and
RT   homology to the alpha subunits of integrins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2776-2780(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=88257215; PubMed=2454931; DOI=10.1083/jcb.106.6.2153;
RA   Arnaout M.A., Gupta S.K., Pierce M.W., Tenen D.G.;
RT   "Amino acid sequence of the alpha subunit of human leukocyte adhesion
RT   receptor Mo1 (complement receptor type 3).";
RL   J. Cell Biol. 106:2153-2158(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93123748; PubMed=8419480;
RA   Fleming J.C., Pahl H.L., Gonzalez D.A., Smith T.F., Tenen D.G.;
RT   "Structural analysis of the CD11b gene and phylogenetic analysis of
RT   the alpha-integrin gene family demonstrate remarkable conservation of
RT   genomic organization and suggest early diversification during
RT   evolution.";
RL   J. Immunol. 150:480-490(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-441.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1152.
RX   MEDLINE=89098893; PubMed=2563162; DOI=10.1073/pnas.86.1.257;
RA   Hickstein D.D., Hickey M.J., Ozols J., Baker D.M., Back A.L.,
RA   Roth G.J.;
RT   "cDNA sequence for the alpha M subunit of the human neutrophil
RT   adherence receptor indicates homology to integrin alpha subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:257-261(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RX   MEDLINE=92073318; PubMed=1683702; DOI=10.1073/pnas.88.23.10525;
RA   Shelley C.S., Arnaout M.A.;
RT   "The promoter of the CD11b gene directs myeloid-specific and
RT   developmentally regulated expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10525-10529(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RC   TISSUE=Blood;
RX   MEDLINE=92144986; PubMed=1346576;
RA   Pahl H.L., Rosmarin A.G., Tenen D.G.;
RT   "Characterization of the myeloid-specific CD11b promoter.";
RL   Blood 79:865-870(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 17-31.
RX   MEDLINE=87076671; PubMed=3539202; DOI=10.1016/0167-4838(86)90037-3;
RA   Pierce M.W., Remold-O'Donnell E., Todd R.F. III, Arnaout M.A.;
RT   "N-terminal sequence of human leukocyte glycoprotein Mo1: conservation
RT   across species and homology to platelet IIb/IIIa.";
RL   Biochim. Biophys. Acta 874:368-371(1986).
RN   [10]
RP   INTERACTION WITH JAM3.
RX   PubMed=12208882; DOI=10.1084/jem.20020267;
RA   Santoso S., Sachs U.J.H., Kroll H., Linder M., Ruf A., Preissner K.T.,
RA   Chavakis T.;
RT   "The junctional adhesion molecule 3 (JAM-3) on human platelets is a
RT   counterreceptor for the leukocyte integrin Mac-1.";
RL   J. Exp. Med. 196:679-691(2002).
RN   [11]
RP   INTERACTION WITH JAM3.
RX   PubMed=15194813; DOI=10.1091/mbc.E04-04-0317;
RA   Zen K., Babbin B.A., Liu Y., Whelan J.B., Nusrat A., Parkos C.A.;
RT   "JAM-C is a component of desmosomes and a ligand for CD11b/CD18-
RT   mediated neutrophil transepithelial migration.";
RL   Mol. Biol. Cell 15:3926-3937(2004).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-900; ASN-940 AND ASN-946,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 148-331.
RX   MEDLINE=95171458; PubMed=7867070; DOI=10.1016/0092-8674(95)90517-0;
RA   Lee J.O., Rieu P., Arnaout M.A., Liddington R.;
RT   "Crystal structure of the A domain from the alpha subunit of integrin
RT   CR3 (CD11b/CD18).";
RL   Cell 80:631-638(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 148-334.
RX   MEDLINE=96363671; PubMed=8747460; DOI=10.1016/S0969-2126(01)00271-4;
RA   Lee J.O., Bankston L.A., Arnaout M.A., Liddington R.C.;
RT   "Two conformations of the integrin A-domain (I-domain): a pathway for
RT   activation?";
RL   Structure 3:1333-1340(1995).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 148-337.
RX   MEDLINE=98362595; PubMed=9687375; DOI=10.1016/S0969-2126(98)00093-8;
RA   Baldwin E.T., Sarver R.W., Bryant G.L. Jr., Curry K.A.,
RA   Fairbanks M.B., Finzel B.C., Garlick R.L., Heinrikson R.L.,
RA   Horton N.C., Kelley L.L., Mildner A.M., Moon J.B., Mott J.E.,
RA   Mutchler V.T., Tomich C.S., Watenpaugh K.D., Wiley V.H.;
RT   "Cation binding to the integrin CD11b I domain and activation model
RT   assessment.";
RL   Structure 6:923-935(1998).
RN   [16]
RP   3D-STRUCTURE MODELING OF 17-616.
RX   MEDLINE=98226734; PubMed=9560195; DOI=10.1073/pnas.95.9.4870;
RA   Oxvig C., Springer T.A.;
RT   "Experimental support for a beta-propeller domain in integrin alpha-
RT   subunits and a calcium binding site on its lower surface.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4870-4875(1998).
RN   [17]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLE, AND VARIANT HIS-77.
RX   PubMed=18204448; DOI=10.1038/ng.71;
RA   Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P.,
RA   Gilkeson G.S., Chen W., Zhu C., McEver R.P., Kimberly R.P.,
RA   Alarcon-Riquelme M.E., Vyse T.J., Li Q.-Z., Wakeland E.K.,
RA   Merrill J.T., James J.A., Kaufman K.M., Guthridge J.M., Harley J.B.;
RT   "A nonsynonymous functional variant in integrin-alpha(M) (encoded by
RT   ITGAM) is associated with systemic lupus erythematosus.";
RL   Nat. Genet. 40:152-154(2008).
RN   [18]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLE.
RX   PubMed=18204446; DOI=10.1038/ng.81;
RA   Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O.,
RA   Kimberly R.P., Moser K.L., Tsao B.P., Vyse T.J., Langefeld C.D.,
RA   Nath S.K., Guthridge J.M., Cobb B.L., Mirel D.B., Marion M.C.,
RA   Williams A.H., Divers J., Wang W., Frank S.G., Namjou B.,
RA   Gabriel S.B., Lee A.T., Gregersen P.K., Behrens T.W., Taylor K.E.,
RA   Fernando M., Zidovetzki R., Gaffney P.M., Edberg J.C., Rioux J.D.,
RA   Ojwang J.O., James J.A., Merrill J.T., Gilkeson G.S., Seldin M.F.,
RA   Yin H., Baechler E.C., Li Q.-Z., Wakeland E.K., Bruner G.R.,
RA   Kaufman K.M., Kelly J.A.;
RT   "Genome-wide association scan in women with systemic lupus
RT   erythematosus identifies susceptibility variants in ITGAM, PXK,
RT   KIAA1542 and other loci.";
RL   Nat. Genet. 40:204-210(2008).
CC   -!- FUNCTION: Integrin alpha-M/beta-2 is implicated in various
CC       adhesive interactions of monocytes, macrophages and granulocytes
CC       as well as in mediating the uptake of complement-coated particles.
CC       It is identical with CR-3, the receptor for the iC3b fragment of
CC       the third complement component. It probably recognizes the R-G-D
CC       peptide in C3b. Integrin alpha-M/beta-2 is also a receptor for
CC       fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides
CC       of fibrinogen gamma chain.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-M
CC       associates with beta-2. Interacts with JAM3.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in monocytes and
CC       granulocytes.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- DISEASE: Genetic variations in ITGAM has been associated with
CC       susceptibility to systemic lupus erythematosus type 6 (SLEB6)
CC       [MIM:609939]. Systemic lupus erythematosus (SLE) is a chronic,
CC       inflammatory and often febrile multisystemic disorder of
CC       connective tissue. It affects principally the skin, joints,
CC       kidneys and serosal membranes. It is thought to represent a
CC       failure of the regulatory mechanisms of the autoimmune system.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC   -!- SIMILARITY: Contains 7 FG-GAP repeats.
CC   -!- SIMILARITY: Contains 1 VWFA domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03925; AAA59544.1; -; mRNA.
DR   EMBL; M18044; AAA59491.1; -; mRNA.
DR   EMBL; S52227; AAB24821.1; -; Genomic_DNA.
DR   EMBL; S52152; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52153; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52154; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52155; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52157; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52159; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52161; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52164; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52165; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52167; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52169; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52170; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52173; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52174; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52180; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52181; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52184; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52189; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52191; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52192; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52203; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52212; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52213; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52216; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52219; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52220; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52221; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52222; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52226; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; BC096346; AAH96346.1; -; mRNA.
DR   EMBL; BC096348; AAH96348.1; -; mRNA.
DR   EMBL; BC099660; AAH99660.1; -; mRNA.
DR   EMBL; J04145; AAA59903.1; -; mRNA.
DR   EMBL; M76724; AAA58410.1; -; Genomic_DNA.
DR   EMBL; M84477; AAA51960.1; -; Genomic_DNA.
DR   IPI; IPI00217987; -.
DR   PIR; A31108; RWHU1B.
DR   RefSeq; NP_000623.2; NM_000632.3.
DR   RefSeq; NP_001139280.1; NM_001145808.1.
DR   UniGene; Hs.172631; -.
DR   PDB; 1A8X; Model; -; A=17-1152.
DR   PDB; 1BHO; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1BHQ; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1IDN; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1IDO; X-ray; 1.70 A; A=143-331.
DR   PDB; 1JLM; X-ray; 2.00 A; A=143-334.
DR   PDB; 1M1U; X-ray; 2.30 A; A=139-331.
DR   PDB; 1MF7; X-ray; 1.25 A; A=144-333.
DR   PDB; 1N9Z; X-ray; 2.50 A; A=145-335.
DR   PDB; 1NA5; X-ray; 1.50 A; A=144-335.
DR   PDB; 2LKE; NMR; -; A=1129-1152.
DR   PDB; 2LKJ; NMR; -; A=1129-1152.
DR   PDB; 3Q3G; X-ray; 2.70 A; E/G/I/L=148-337.
DR   PDB; 3QA3; X-ray; 3.00 A; E/G/I/L=148-337.
DR   PDBsum; 1A8X; -.
DR   PDBsum; 1BHO; -.
DR   PDBsum; 1BHQ; -.
DR   PDBsum; 1IDN; -.
DR   PDBsum; 1IDO; -.
DR   PDBsum; 1JLM; -.
DR   PDBsum; 1M1U; -.
DR   PDBsum; 1MF7; -.
DR   PDBsum; 1N9Z; -.
DR   PDBsum; 1NA5; -.
DR   PDBsum; 2LKE; -.
DR   PDBsum; 2LKJ; -.
DR   PDBsum; 3Q3G; -.
DR   PDBsum; 3QA3; -.
DR   ProteinModelPortal; P11215; -.
DR   SMR; P11215; 17-335, 345-1138.
DR   MINT; MINT-1489258; -.
DR   STRING; P11215; -.
DR   PhosphoSite; P11215; -.
DR   DMDM; 1708572; -.
DR   PRIDE; P11215; -.
DR   Ensembl; ENST00000287497; ENSP00000287497; ENSG00000169896.
DR   GeneID; 3684; -.
DR   KEGG; hsa:3684; -.
DR   UCSC; uc002ebq.1; human.
DR   CTD; 3684; -.
DR   GeneCards; GC16P031271; -.
DR   H-InvDB; HIX0012987; -.
DR   HGNC; HGNC:6149; ITGAM.
DR   HPA; CAB025091; -.
DR   HPA; HPA002274; -.
DR   MIM; 120980; gene.
DR   MIM; 609939; phenotype.
DR   neXtProt; NX_P11215; -.
DR   PharmGKB; PA29949; -.
DR   eggNOG; NOG301393; -.
DR   GeneTree; ENSGT00650000092931; -.
DR   HOGENOM; HBG443936; -.
DR   HOVERGEN; HBG100530; -.
DR   InParanoid; P11215; -.
DR   KO; K06461; -.
DR   OMA; VTFNITF; -.
DR   OrthoDB; EOG4TQM86; -.
DR   PhylomeDB; P11215; -.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_604; Hemostasis.
DR   NextBio; 14419; -.
DR   ArrayExpress; P11215; -.
DR   Bgee; P11215; -.
DR   CleanEx; HS_ITGAM; -.
DR   Genevestigator; P11215; -.
DR   GermOnline; ENSG00000169896; Homo sapiens.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0001948; F:glycoprotein binding; IPI:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR002035; VWF_A.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Integrin;
KW   Magnesium; Membrane; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Systemic lupus erythematosus; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     16
FT   CHAIN        17   1152       Integrin alpha-M.
FT                                /FTId=PRO_0000016289.
FT   TOPO_DOM     17   1104       Extracellular (Potential).
FT   TRANSMEM   1105   1128       Helical; (Potential).
FT   TOPO_DOM   1129   1152       Cytoplasmic (Potential).
FT   REPEAT       18     75       FG-GAP 1.
FT   REPEAT       76    135       FG-GAP 2.
FT   DOMAIN      150    328       VWFA.
FT   REPEAT      339    390       FG-GAP 3.
FT   REPEAT      391    444       FG-GAP 4.
FT   REPEAT      445    503       FG-GAP 5.
FT   REPEAT      506    564       FG-GAP 6.
FT   REPEAT      569    629       FG-GAP 7.
FT   CA_BIND     465    473       Potential.
FT   CA_BIND     529    537       Potential.
FT   CA_BIND     592    600       Potential.
FT   MOTIF      1131   1135       GFFKR motif.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    240    240       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    391    391       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    469    469       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    692    692       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    696    696       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    734    734       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    801    801       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    880    880       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    900    900       N-linked (GlcNAc...).
FT   CARBOHYD    911    911       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    940    940       N-linked (GlcNAc...).
FT   CARBOHYD    946    946       N-linked (GlcNAc...).
FT   CARBOHYD    978    978       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    993    993       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1021   1021       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1044   1044       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1050   1050       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1075   1075       N-linked (GlcNAc...) (Potential).
FT   DISULFID     66     73       By similarity.
FT   DISULFID    105    123       By similarity.
FT   DISULFID    654    711       By similarity.
FT   DISULFID    770    776       By similarity.
FT   DISULFID    847    864       By similarity.
FT   DISULFID    998   1022       By similarity.
FT   DISULFID   1027   1032       By similarity.
FT   VARIANT      77     77       R -> H (influences susceptibility to SLE;
FT                                dbSNP:rs1143679).
FT                                /FTId=VAR_043870.
FT   VARIANT     441    441       M -> T (in dbSNP:rs11861251).
FT                                /FTId=VAR_043871.
FT   VARIANT     858    858       A -> V (in dbSNP:rs1143683).
FT                                /FTId=VAR_043872.
FT   VARIANT    1146   1146       P -> S (in dbSNP:rs1143678).
FT                                /FTId=VAR_043873.
FT   CONFLICT    499    499       G -> GQ (in Ref. 1 and 6).
FT   CONFLICT    965    965       L -> P (in Ref. 2 and 3).
FT   STRAND      149    156
FT   HELIX       163    180
FT   STRAND      185    200
FT   HELIX       202    207
FT   HELIX       211    215
FT   HELIX       227    236
FT   TURN        237    239
FT   HELIX       241    243
FT   STRAND      249    259
FT   HELIX       268    270
FT   HELIX       272    277
FT   STRAND      280    288
FT   HELIX       289    291
FT   HELIX       294    303
FT   HELIX       308    311
FT   STRAND      312    317
FT   HELIX       318    324
FT   HELIX       325    333
SQ   SEQUENCE   1152 AA;  127179 MW;  DF77408ED5EE25F9 CRC64;
     MALRVLLLTA LTLCHGFNLD TENAMTFQEN ARGFGQSVVQ LQGSRVVVGA PQEIVAANQR
     GSLYQCDYST GSCEPIRLQV PVEAVNMSLG LSLAATTSPP QLLACGPTVH QTCSENTYVK
     GLCFLFGSNL RQQPQKFPEA LRGCPQEDSD IAFLIDGSGS IIPHDFRRMK EFVSTVMEQL
     KKSKTLFSLM QYSEEFRIHF TFKEFQNNPN PRSLVKPITQ LLGRTHTATG IRKVVRELFN
     ITNGARKNAF KILVVITDGE KFGDPLGYED VIPEADREGV IRYVIGVGDA FRSEKSRQEL
     NTIASKPPRD HVFQVNNFEA LKTIQNQLRE KIFAIEGTQT GSSSSFEHEM SQEGFSAAIT
     SNGPLLSTVG SYDWAGGVFL YTSKEKSTFI NMTRVDSDMN DAYLGYAAAI ILRNRVQSLV
     LGAPRYQHIG LVAMFRQNTG MWESNANVKG TQIGAYFGAS LCSVDVDSNG STDLVLIGAP
     HYYEQTRGGQ VSVCPLPRGR ARWQCDAVLY GEQGQPWGRF GAALTVLGDV NGDKLTDVAI
     GAPGEEDNRG AVYLFHGTSG SGISPSHSQR IAGSKLSPRL QYFGQSLSGG QDLTMDGLVD
     LTVGAQGHVL LLRSQPVLRV KAIMEFNPRE VARNVFECND QVVKGKEAGE VRVCLHVQKS
     TRDRLREGQI QSVVTYDLAL DSGRPHSRAV FNETKNSTRR QTQVLGLTQT CETLKLQLPN
     CIEDPVSPIV LRLNFSLVGT PLSAFGNLRP VLAEDAQRLF TALFPFEKNC GNDNICQDDL
     SITFSFMSLD CLVVGGPREF NVTVTVRNDG EDSYRTQVTF FFPLDLSYRK VSTLQNQRSQ
     RSWRLACESA SSTEVSGALK STSCSINHPI FPENSEVTFN ITFDVDSKAS LGNKLLLKAN
     VTSENNMPRT NKTEFQLELP VKYAVYMVVT SHGVSTKYLN FTASENTSRV MQHQYQVSNL
     GQRSLPISLV FLVPVRLNQT VIWDRPQVTF SENLSSTCHT KERLPSHSDF LAELRKAPVV
     NCSIAVCQRI QCDIPFFGIQ EEFNATLKGN LSFDWYIKTS HNHLLIVSTA EILFNDSVFT
     LLPGQGAFVR SQTETKVEPF EVPNPLPLIV GSSVGGLLLL ALITAALYKL GFFKRQYKDM
     MSEGGPPGAE PQ
//
